Older Inflammatory Bowel Disease Patients at Much Higher Risk of Cancer, Study Reports

Older Inflammatory Bowel Disease Patients at Much Higher Risk of Cancer, Study Reports
Older people with inflammatory bowel disease have a higher cancer rate than younger IBD patients and the general population, a study reports. The research, "Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients," appeared in the journal Drugs & Aging. The number of people with IBD, which includes Crohn's and ulcerative colitis, is increasing.  Because people are living longer, the number of older IBD patients is expected to increase dramatically. Older people are also prone to developing other conditions, including high blood pressure and cancer. Researchers wanted to determine the risk of IBD patients developing cancer. They looked at patient records between 2010 and 2014 in the Truven Health Analytics MarketScan database. It covers health claims filed with U.S. insurance companies and the government's Medicare insurance program. The database included 54,971 IBD patients between 18 and 64 years of age and 8,788 who were 65 and older. Researchers followed the younger group a median of 22 months and the older group 24 months. They excluded patients who had cancer before the start of their study. When the research began, 96 percent of the older patients were receiving corticosteroids, versus 90 percent of the younger ones. But higher percentages of the younger group were receiving biologics and immunomodulators, a trend that has been studied before.The figures were 19 percent of the younger group using biologics, versus 6 percent of the older group,
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *